{"id":1783,"date":"2023-10-26T13:16:35","date_gmt":"2023-10-26T17:16:35","guid":{"rendered":"https:\/\/research.ncsu.edu\/win\/?p=1783"},"modified":"2023-11-17T13:20:35","modified_gmt":"2023-11-17T18:20:35","slug":"win-backs-sonovascular-ahead-of-clinical-trials","status":"publish","type":"post","link":"https:\/\/research.ncsu.edu\/win\/win-backs-sonovascular-ahead-of-clinical-trials\/","title":{"rendered":"WIN Backs SonoVascular Ahead of Clinical Trials"},"content":{"rendered":"\n
Research Triangle Park medical company SonoVascular is one step closer to improving treatment for those with venous thromboembolism after securing capital and resources from the Wolfpack Investor Network.<\/p>\n\n\n\n